Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A
- PMID: 12719805
- DOI: 10.1007/s00134-003-1748-5
Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A
Abstract
Objective: To report the use of extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation in a patient with hemophilia A and dilated cardiomyopathy.
Design: Case report.
Interventions and results: During ECMO factor VIII concentrate was administered to maintain a factor VIII level close to 50% of normal control both to decrease the risk of bleeding and to allow standard anticoagulation with heparin. The patient developed an inhibitor to exogenous factor VIII during hospitalization, which was successfully managed with a high-dose continuous infusion of factor VIII during ECMO, the transplant operation, and the postoperative period.
Conclusions: We report the successful use of ECMO as a bridge to cardiac transplantation in a patient with hemophilia A and low-level factor VIII inhibitors.
Similar articles
-
Ventricular assist device as a bridge to transplant, and extracorporeal membrane oxygenation for primary graft failure in a child with hemophilia A.Pediatr Crit Care Med. 2011 Nov;12(6):e432-5. doi: 10.1097/PCC.0b013e31822f1b63. Pediatr Crit Care Med. 2011. PMID: 21926657
-
Venoarterial Extracorporeal Membrane Oxygenation Support as a Bridge to Heart Transplant: Report of 3 Cases.Exp Clin Transplant. 2016 Nov;14(Suppl 3):121-124. Exp Clin Transplant. 2016. PMID: 27805530
-
Sequential use of extracorporeal membrane oxygenation and the Berlin Heart Left Ventricular Assist Device for 106-day bridge to transplant in a two-year-old child.ASAIO J. 2005 Sep-Oct;51(5):668-9. doi: 10.1097/01.mat.0000174624.36385.94. ASAIO J. 2005. PMID: 16322738
-
Balancing anticoagulation and hemostasis in an infant with severe hemophilia A during cardiac transplantation: Review of the literature and development of a surgical protocol.Pediatr Blood Cancer. 2024 Jan;71(1):e30759. doi: 10.1002/pbc.30759. Epub 2023 Nov 7. Pediatr Blood Cancer. 2024. PMID: 37935644 Review.
-
Hemophilia. Strategies for the treatment of inhibitor patients.Haematologica. 2000 Oct;85(10 Suppl):15-20. Haematologica. 2000. PMID: 11187863 Review.
Cited by
-
Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B.Cardiol Rev. 2015 Mar-Apr;23(2):53-68. doi: 10.1097/CRD.0000000000000045. Cardiol Rev. 2015. PMID: 25436468 Free PMC article. Review.
-
Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.Intensive Care Med. 2004 Aug;30(8):1514-25. doi: 10.1007/s00134-004-2358-6. Epub 2004 Jun 26. Intensive Care Med. 2004. PMID: 15292983 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical